Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidine.
In this article we show that the cytidine analog 5-azacytidine is able to induce differentiation of the human leukemia K-562 cell line. Erythroid induction is associated with (a) an increase of the overall globin synthesis and globin mRNA accumulation, (b) a relative increase of fetal with respect to embryonic globins, and (c) a decrease of the proliferative capacity of hemoglobin-containing cells. In addition, we have analysed the DNA methylation pattern at the cleavage sites of MspI and HpaII restriction enzymes, which are known to cleave differently CCGG DNA sequences when 5-methylcytosine is present. These experiments indicate that in K-562 cells treated with 5-azacytidine, DNA becomes hypomethylated, suggesting that genetic programmes leading to an erythroid phenotype may be activated by a reduction of DNA methylation.
D001374:Azacitidine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D004247:DNA / Q000378:metabolism; D004262:DNA Restriction Enzymes / Q000494:pharmacology; D019003:Deoxyribonuclease HpaII; D004912:Erythrocytes / Q000166:cytology*; D005319:Fetal Hemoglobin / Q000096:biosynthesis; D005786:Gene Expression Regulation / Q000187:drug effects; D005914:Globins / Q000096:biosynthesis / Q000235:genetics; D006454:Hemoglobins / Q000096:biosynthesis; D006455:Hemoglobins, Abnormal / Q000096:biosynthesis; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology*; D008745:Methylation; D012333:RNA, Messenger / Q000378:metabolism
D006454:Hemoglobins; D006455:Hemoglobins, Abnormal; D012333:RNA, Messenger; C030447:hemoglobin Portland; D005914:Globins; D004247:DNA; D005319:Fetal Hemoglobin; D004262:DNA Restriction Enzymes; D019003:Deoxyribonuclease HpaII; D001374:Azacitidine